BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30617729)

  • 1. Feasibility of Hyperfunctioning Parathyroid Gland Localization Using [
    Akintayo AA; Abiodun-Ojo OA; Weber C; Sharma J; Cohen C; Sica G; Halkar R; Goodman MM; Schuster DM
    Mol Imaging Biol; 2019 Oct; 21(5):818-824. PubMed ID: 30617729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
    Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of 99mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Mandic A; Kraljevic I; Skoric Polovina T; Zibar Tomsic K; Dusek T; Balasko A; Solak M; Kastelan D
    Exp Clin Endocrinol Diabetes; 2024 Apr; 132(4):216-220. PubMed ID: 38320618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.
    Araz M; Soydal Ç; Özkan E; Kir MK; İbiş E; Güllü S; Erdoğan MF; Emral R; Küçük ÖN
    Nucl Med Commun; 2018 Nov; 39(11):989-994. PubMed ID: 30138157
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cuderman A; Senica K; Rep S; Hocevar M; Kocjan T; Sever MJ; Zaletel K; Lezaic L
    J Nucl Med; 2020 Apr; 61(4):577-583. PubMed ID: 31562221
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
    J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism.
    Vestergaard S; Gerke O; Bay M; Madsen AR; Stilgren L; Ejersted C; Rewers KI; Jakobsen N; Asmussen JT; Braad PE; Petersen H; Thomassen A; Schifter S
    Mol Imaging Biol; 2023 Aug; 25(4):720-726. PubMed ID: 36881250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
    Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients.
    Morland D; Lalire P; Deguelte S; Zalzali M; Richard C; Dejust S; Boulagnon C; Ly S; Papathanassiou D; Delemer B
    Medicine (Baltimore); 2020 Jan; 99(2):e18681. PubMed ID: 31914064
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PETC/CT with
    Bossert I; Chytiris S; Hodolic M; Croce L; Mansi L; Chiovato L; Mariani G; Trifirò G
    J Endocrinol Invest; 2019 Apr; 42(4):419-426. PubMed ID: 30094743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcemic primary hyperparathyroidism: 99mTc SestaMibi SPECT/CT results compare with hypercalcemic hyperparathyroidism.
    Musumeci M; Pereira LV; San Miguel L; Cianciarelli C; Vazquez EC; Mollerach AM; Arma IJ; Hume I; Galich AM; Collaud C
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):831-836. PubMed ID: 34951035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands.
    Kaczirek K; Prager G; Kienast O; Dobrozemsky G; Dudczak R; Niederle B; Kurtaran A
    Nuklearmedizin; 2003 Oct; 42(5):220-3. PubMed ID: 14571319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and Comparison of
    Whitman J; Allen IE; Bergsland EK; Suh I; Hope TA
    J Nucl Med; 2021 Sep; 62(9):1285-1291. PubMed ID: 33452040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
    Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
    Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
    Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of
    Grimaldi S; Young J; Kamenicky P; Hartl D; Terroir M; Leboulleux S; Berdelou A; Hadoux J; Hescot S; Remy H; Baudin E; Schlumberger M; Deandreis D
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1772-1780. PubMed ID: 29680989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EANM practice guidelines for parathyroid imaging.
    Petranović Ovčariček P; Giovanella L; Carrió Gasset I; Hindié E; Huellner MW; Luster M; Piccardo A; Weber T; Talbot JN; Verburg FA
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2801-2822. PubMed ID: 33839893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
    Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM
    J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.